Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Lyra Therapeutics Inc. LYRA

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration.


Top institutional share ownership of Lyra Therapeutics Inc

Name Shares Shares % change Value Value % change
Perceptive Advisors Llc 9,146,730 183.8% $51,679 298.9%
Pura Vida Investments, Llc 2,576,196 394.9% $14,556 595.5%
Nantahala Capital Management, LLC 2,369,668 $13,389
Samsara BioCapital, LLC 1,777,251 $10,041
VR Adviser, LLC 924,170 $5,222
Vanguard Group Inc 675,669 208.9% $3,817 334.2%
Soleus Capital Management, L.P. 592,417 $3,347
Ikarian Capital, LLC 347,338 -17.8% $1,963 15.6%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 346,005 106.6% $1,955 190.3%
VEXMX - Vanguard Extended Market Index Fund Investor Shares 316,335 623.0% $1,787 921.1%

Top institutional buyers of Lyra Therapeutics Inc

Name Shares % change Value % change Shares Value
VEXMX - Vanguard Extended Market Index Fund Investor Shares 623.0% 921.1% 316,335 $1,787
Pura Vida Investments, Llc 394.9% 595.5% 2,576,196 $14,556
Geode Capital Management, Llc 221.6% 353.3% 120,476 $680
Vanguard Group Inc 208.9% 334.2% 675,669 $3,817
Perceptive Advisors Llc 183.8% 298.9% 9,146,730 $51,679
Renaissance Technologies Llc 134.3% 231.4% 41,000 $232
BlackRock Inc. 118.8% 205.2% 41,582 $235
IWC - iShares Micro-Cap ETF 115.8% 206.6% 33,258 $188
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 106.6% 190.3% 346,005 $1,955
Two Sigma Advisers, Lp 92.0% 171.3% 38,400 $217

Top institutional sellers of Lyra Therapeutics Inc

Name Shares % change Value % change Shares Value
Millennium Management Llc -21.3% 10.6% 88,705 $501
Ikarian Capital, LLC -17.8% 15.6% 347,338 $1,963
BRSIX - Ultra-Small Company Market Fund Class N -15.4% 18.8% 55,000 $311
Bridgeway Capital Management Inc -15.0% 19.3% 56,900 $321
Clearline Capital LP -0.7% 39.6% 119,128 $673
Boothbay Fund Management, Llc -0.4% 40.0% 38,374 $217

Information provided by Fintel.io